Chemical Compound

Daunorubicin Hydrochloride Imp. D (EP); Daunorubicin Imp. D (EP); Epirubicin Hydrochloride Imp. C (EP); Epirubicin Imp. C (EP); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-; Adriamycin, hydrochloride; ADM hydrochloride; ADR; Adriablastina CS; Adriacin; Adriamycin; Adriblastin; Adriblastina; Adriblastina RD; DOX HCl; Doxorubicin Hydrochloride; FI 106; FI 6804; Hydroxydaunorubicin hydrochloride; Lipo-Dox; Daunorubicin Hydrochloride Impurity D as Hydrochloride; Epirubicin Hydrochloride Impurity C as Hydrochloride; Daunorubicin Impurity D as Hydrochloride; Epirubicin Impurity C as Hydrochl

CAS Registry Number 25316-40-9
返回搜索 申请报价
Daunorubicin Hydrochloride Imp. D (EP); Daunorubicin Imp. D (EP); Epirubicin Hydrochloride Imp. C (EP); Epirubicin Imp. C (EP); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-; Adriamycin, hydrochloride; ADM hydrochloride; ADR; Adriablastina CS; Adriacin; Adriamycin; Adriblastin; Adriblastina; Adriblastina RD; DOX HCl; Doxorubicin Hydrochloride; FI 106; FI 6804; Hydroxydaunorubicin hydrochloride; Lipo-Dox; Daunorubicin Hydrochloride Impurity D as Hydrochloride; Epirubicin Hydrochloride Impurity C as Hydrochloride; Daunorubicin Impurity D as Hydrochloride; Epirubicin Impurity C as Hydrochl 结构式
Primary record

Daunorubicin Hydrochloride Imp. D (EP); Daunorubicin Imp. D (EP); Epirubicin Hydrochloride Imp. C (EP); Epirubicin Imp. C (EP); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-; Adriamycin, hydrochloride; ADM hydrochloride; ADR; Adriablastina CS; Adriacin; Adriamycin; Adriblastin; Adriblastina; Adriblastina RD; DOX HCl; Doxorubicin Hydrochloride; FI 106; FI 6804; Hydroxydaunorubicin hydrochloride; Lipo-Dox; Daunorubicin Hydrochloride Impurity D as Hydrochloride; Epirubicin Hydrochloride Impurity C as Hydrochloride; Daunorubicin Impurity D as Hydrochloride; Epirubicin Impurity C as Hydrochl

库存
1,566 克
纯度
99.8 %
CAS
25316-40-9

化合物标识与属性

CAS
25316-40-9
PubChem CID
443939
SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
Canonical SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl

名称与同义词

  • Doxorubicin Hydrochloride
  • Adriamycin
  • Doxorubicin HCl
  • 25316-40-9
  • Adriblastina
  • Adriacin
  • Rubex
  • Doxil
  • Adriblastin
  • Adriamycin PFS
  • Adriamycin RDF
  • Caelyx
  • Adriablastina cs
  • Adrosal
  • Duxocin
  • Lipodox
  • doxorubicin.HCl
  • adriamycine
  • drochloride
  • Farmiblastina
  • Adrimedac
  • Doxorubin
  • Resmycin
  • Doxolem
  • Ellence
  • Lipo-Dox
  • ADM hydrochloride
  • Adriblastina RD
  • Doxourbicin HCl
  • ADRIAMYCIN HYDROCHLORIDE
  • Urokit Doxo cell
  • Urokit Doxo-cell
  • icin Hydrochloride
  • Adriamycin (TN)
  • DOXO cell
  • DOXO-cell
  • Doxorubicin citrate
  • Hydroxydaunorubicin hydrochloride
  • Adriacin (TN)
  • Prestwick_188
  • Doxorubicin (Adriamycin) HCl
  • ADRIAMYCIN, HYDROCHLORIDE
  • Doxil (TN)
  • Rubex (TN)
  • Doxorubicin (hydrochloride)
  • Doxorubicini hydrochloridum
  • RefChem:5781
  • hydroxydaunomycin hydrochloride
  • MFCD00077757
  • AC1L9FFU
  • Adriblastina hydrochloride
  • Doxorubicin citric acid salt
  • Doxorubicine hydrochloride
  • 82F2G7BL4E
  • ADRIAMYCIN [IARC]
  • DOXIL (LIPOSOMAL)
  • Doxorubicin hydrochloride?
  • UNII-82F2G7BL4E
  • 2-Amino-3-chloropyrazine
  • Hydrochloride, Doxorubicin
  • CCRIS 740
  • DTXSID3030636
  • D0F4KU
  • Chloridrato de Doxorrubicina
  • MLS001401460
  • SCHEMBL3242
  • Doxorubicin hydrochloride RS
  • DSSTox_CID_10636
  • DSSTox_RID_80678
  • Doxorubicin hydrochloride [JAN]
  • DSSTox_GSID_45111
  • Doxorubicin hydrochloride CRS
  • DTXCID1010636
  • C27H30ClNO11
  • MLS000028393
  • MLS000049969
  • MLS000049970
  • MLS000049971
  • MLS000070047
  • MLS000392861
  • MLS000392871
  • MLS000392881
  • MLS000392891
  • MLS000392901
  • MLS000759533
  • MLS001055359
  • C27H29NO11.ClH
  • CAS-NOCAS_45111
  • KW-125
  • Liposomal doxorubicin hydrochloride
  • MWWSFMDVAYGXBV-RUELKSSGSA-N
  • CHEMBL359744
  • orb1310036
  • SCHEMBL29349501
  • SCHEMBL29567127
  • CHEBI:31522
  • EINECS 246-818-3
  • AOB5216
  • Doxorubicin hydrochloride [USP:JAN]
  • Doxorubicin hydrochloride solution
  • BCPP000429
  • GLXC-06425
  • HMS1569G18
  • HMS6018M19
  • KUC110341C
  • MSK001346A
  • NSC 123127
  • doxorubicin hydrochloride, Liposomal
  • DRG-0047
  • EX-A1337
  • FI 6804
  • 14-Hydroxydaunorubicin Hydrochloride
  • Adriamycin hydrochloride-DNA complex
  • C27-H29-N-O11.Cl-H
  • Tox21_110050
  • Tox21_112061
  • Tox21_202483
  • Adriamycin (Doxorubicin Hydrochloride
  • BBF-03859
  • CD0186
  • CID443939
  • Doxorubicin hydrochloride (liposomal)
  • DOXORUBICIN HYDROCHLORIDE LIPOSOME
  • EBC-11150
  • FI 106
  • FI-106
  • HB4183
  • HY-15142R
  • NSC123127
  • s1208
  • CPD000058570
  • DOXORUBICIN HYDROCHLORIDE 25MG
  • SMR000058570
  • AKOS007930231
  • AKOS015920241
  • Doxorubicin hydrochloride (JP18/USP)
  • Tox21_110050_1
  • ACN-036671
  • ACN-036867
  • AD15377
  • BCP9000237
  • CCG-100975
  • CS-1239
  • Doxorubicin (hydrochloride) (Standard)
  • DOXORUBICIN HYDROCHLORIDE 100MG
  • F.I 106
  • NC00225
  • NSC-123127
  • RL02839
  • 2-Chloro-4-fluorobenzenesulphonylchloride
  • 3-Hydroxyacetyldaunorubicin Hydrochloride
  • Daunorubicin EP Impurity D hydrochloride
  • DOXORUBICIN HYDROCHLORIDE [MART.]
  • DOXORUBICIN HYDROCHLORIDE [VANDF]
  • NCGC00014486-01
  • NCGC00024415-33
  • NCGC00024415-36
  • NCGC00163543-01
  • NCGC00260032-01
  • NCGC00263918-03
  • AD184265
  • AS-31687
  • BD164391
  • BR-72874
  • DOXORUBICIN HYDROCHLORIDE [USP-RS]
  • DOXORUBICIN HYDROCHLORIDE [WHO-DD]
  • DOXORUBICIN HYDROCHLORIDE [WHO-IP]
  • HY-15142
  • SAM001246768
  • SY059508
  • KSC-230-184-1
  • AB0069925
  • CAS-25316-40-9
  • Doxorubicin hydrochloride =95% (by HPLC)
  • DOXORUBICIN HYDROCHLORIDE [EMA EPAR]
  • ST2419270
  • A1832
  • Doxorubicin hydrochloride - Bio-X trade mark
  • Doxorubicin liposomal complex of the hydrochloride
  • FT-0625594
  • FT-0777536
  • NS00093622
  • A10041
  • D01275
  • DOXORUBICIN HYDROCHLORIDE [EP MONOGRAPH]
  • DOXORUBICIN HYDROCHLORIDE [ORANGE BOOK]
  • EN300-123444
  • W-5070
  • 33804-EP2275420A1
  • 33804-EP2295055A2
  • 33804-EP2295416A2
  • 33804-EP2298748A2
  • 33804-EP2298764A1
  • 33804-EP2298765A1
  • 33804-EP2305642A2
  • 33804-EP2308833A2
  • 33804-EP2311453A1
  • DOXORUBICIN HYDROCHLORIDE [USP MONOGRAPH]
  • 139293-EP2270008A1
  • 139293-EP2292617A1
  • 316D409
  • A817779
  • DOXORUBICIN HYDROCHLORIDE LIPOSOME [VANDF]
  • DOXORUBICINI HYDROCHLORIDUM [WHO-IP LATIN]
  • F021790
  • SR-01000003049
  • (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
  • Doxorubicin hydrochloride, 10 mg/ml aqueous solution
  • Doxorubicin hydrochloride, 98.0-102.0% (HPLC)
  • IMX-110 COMPONENT DOXORUBICIN HYDROCHLORIDE
  • LIPOSOMAL DOXORUBICIN HYDROCHLORIDE [WHO-DD]
  • SR-01000003049-5
  • Q27032359
  • SR-01000003049-10
  • 23214-92-8
  • Z1557399790
  • Doxorubicin hydrochloride, 98%, an antibiotic agent - 1G 1g
  • DOXORUBICIN LIPOSOMAL COMPLEX OF THE HYDROCHLORIDE [MI]
  • (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
  • (8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
  • (8S,10S)-10-{[(2R,4S,5S,6S)-4-AMINO-5-HYDROXY-6-METHYLOXAN-2-YL]OXY}-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE HYDROCHLORIDE
  • (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
  • 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
  • Doxorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard
  • Doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
  • Doxorubicin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
  • Doxorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard
  • (1S,3S)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside--hydrogen chloride (1/1)
  • (2S,4S)-4-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-2-hydroxyacetyl-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride
  • (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
  • (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
  • (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen
  • (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hy
  • (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
  • (8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
  • (8S,10S)-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-GLYCOLOYL-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-5,12-NAPHTHACENEDIONE HYDROCHLORIDE
  • (8S,10S)-10-[[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
  • (8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
  • 10-[(3-Amino-2,3,6-trideoxy-?-L-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-5,12-naphthacenedione hydrochloride
  • 5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYLACETYL)-1-METHOXY-, HYDROCHLORIDE (8S-CIS)-
  • 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
  • 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
  • 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride, (8S-cis)-
  • 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8S-cis)-
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
  • 5,12-NAPHTHACENEDIONE, 10-[(3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY]-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METOXY-, HYDROCHLORIDE, (8S-CIS)-
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-|_-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-
  • Daunorubicin Hydrochloride Imp. D (EP); Daunorubicin Imp. D (EP); Epirubicin Hydrochloride Imp. C (EP); Epirubicin Imp. C (EP); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-; Adriamycin, hydrochloride; ADM hydrochloride; ADR; Adriablastina CS; Adriacin; Adriamycin; Adriblastin; Adriblastina; Adriblastina RD; DOX HCl; Doxorubicin Hydrochloride; FI 106; FI 6804; Hydroxydaunorubicin hydrochloride; Lipo-Dox; Daunorubicin Hydrochloride Impurity D as Hydrochloride; Epirubicin Hydrochloride Impurity C as Hydrochloride; Daunorubicin Impurity D as Hydrochloride; Epirubicin Impurity C as Hydrochl
  • DOX
  • L-Lyxo-hexopyranoside, 3b-glycol-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-, hydrochloride